Pharming Group N.V. - ADR

XNAS:PHAR  
16.31
0.00 (0.00%)
5:31:53 PM EDT: $16.35 +0.04 (+0.25%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.14B
Current PE425.24
Forward PE 95.94
2yr Forward PE 81.55
See more stats
Estimates Current Quarter
Revenue$93.75 Million
Adjusted EPS$0.01
See more estimates
10-Day MA$15.94
50-Day MA$16.83
200-Day MA$14.71
See more pivots

Pharming Group N.V. - ADR Stock, XNAS:PHAR

Vondellaan 47, Leiden, Zuid-Holland 2332 AA
Netherlands
Phone: +31.71.524.74.00
Number of Employees:
http://www.pharming.com

Description

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST�®, Joenja�®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.